Zika Virus
Issue 26  |   February 2016
Euroimmun releases the first commercial
serological diagnostic tests for Zika Virus

Zika Virus

Euroimmun has released two commercial serological diagnostic tests for Zika Virus for ELISA and IIFT methods

The first complete test package has been developed for the serological detection of Zika virus infections. ELISA and IIFT tests allow for determination of IgG and IgM antibodies against the virus in blood samples.

The Euroimmun tests are suitable for fast screening of large sample numbers, and therefore enable monitoring of virus spread. These tests can detect both acute infections (in most cases from the fifth day after onset of symptoms) and past infections. Test systems for direct virus detection (e.g. PCR) are only able to detect infections up to five days after onset of symptoms - after this, the virus itself is no longer detectable.

Anti-Zika Virus ELISA (IgG/IgM) 

This is based on very specific recombinant NS1 antigens, which are produced in Euroimmun laboratories. Reduced cross-reactivity to other flaviviruses (including TBEV or YFV vaccinated patients) allows for very high specificity. Positive results are a clear indicator of infection. CE marked. Available now.
Order code: EI 2668-9601 G/M

IIFT Arboviral Fever Mosaic 2 (IgG/IgM) 

This mosaic allows for investigation of other viral fever diseases in parallel. This is helpful for differential diagnosis, given the similarity in symptoms and transmission with Dengue and Chikungunya. Zika positive fluorescence IIFT shown in header image. CE marked. Available now.
Order code: FI 2668-1 G/M

Request a Quote
Contact Australia
Contact NZ
Copyright © 2016 ESL Biosciences (New Zealand) Limited. All rights reserved.
unsubscribe from this list  |  update subscription preferences